Medicare Enrolled

Dr. Basher Atiquzzaman, M.D.

Gastroenterology · Kissimmee, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2400 N ORANGE BLOSSOM TRAIL, Kissimmee, FL 34744
4079326193
In practice since 2006 (19 years)
NPI: 1033159819 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Atiquzzaman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atiquzzaman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Atiquzzaman

Dr. Basher Atiquzzaman is a gastroenterology specialist in Kissimmee, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Atiquzzaman performed 747 Medicare services across 447 unique beneficiaries.

Between the years covered by Open Payments, Dr. Atiquzzaman received a total of $9,754 from 51 pharmaceutical and/or device companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Atiquzzaman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 47% volume in FL $9,754 industry payments

Medicare Practice Summary

Medicare Utilization ↗
747
Medicare services
Top 47% in FL for gastroenterology
447
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 245 $90 $262
Tissue pathology examination, moderate complexity 122 $26 $65
New patient office visit (45-59 min) 89 $114 $342
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month 68 $37 $56
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month 64 $48 $74
Upper GI endoscopy with biopsy 54 $81 $785
Office visit, established patient (20-29 min) 26 $65 $184
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 26 $164 $706
Colonoscopy with biopsy 24 $118 $906
Special stained specimen slides to identify organisms including interpretation and report 18 $65 $164
New patient office visit (30-44 min) 11 $72 $228
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,754
Total received (2018-2024)
Avg $1,393/year across 7 years
Top 17% in FL for gastroenterology
51
Companies
391
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,735 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,176
2023
$2,530
2022
$1,569
2021
$1,558
2020
$239
2019
$510
2018
$1,172

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,351
AstraZeneca Pharmaceuticals LP
$1,229
AbbVie Inc.
$1,116
ABBVIE INC.
$670
PFIZER INC.
$486
Celgene Corporation
$450
GlaxoSmithKline, LLC.
$364
Gilead Sciences, Inc.
$356
Janssen Scientific Affairs, LLC
$339
Axonics, Inc.
$273
Synergy Pharmaceuticals Inc
$258
Nestle HealthCare Nutrition Inc.
$252
Regeneron Healthcare Solutions, Inc.
$242
Intercept Pharmaceuticals, Inc.
$207
RedHill Biopharma Inc.
$206
AbbVie, Inc.
$179
Ethicon US, LLC
$178
Ardelyx, Inc.
$159
Amgen Inc.
$125
E.R. Squibb & Sons, L.L.C.
$125
EVOKE PHARMA, INC.
$120
Takeda Pharmaceuticals U.S.A., Inc.
$114
Bayer HealthCare Pharmaceuticals Inc.
$94
NESTLE HEALTHCARE NUTRITION INC.
$78
Phathom Pharmaceuticals, Inc.
$67
Madrigal Pharmaceuticals
$64
GENZYME CORPORATION
$58
Braintree Laboratories, Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Ferring Pharmaceuticals Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$32
Covidien LP
$30
Genentech USA, Inc.
$30
Sumitomo Pharma America, Inc.
$29
UCB, Inc.
$29
Micro-tech Endoscopy USA, Inc.
$26
Alnylam Pharmaceuticals Inc.
$26
Abbott Laboratories
$25
Merck Sharp & Dohme LLC
$23
Novo Nordisk Inc
$23
Celltrion USA Inc.
$19
Lilly USA, LLC
$19
Janssen Biotech, Inc.
$18
Medtronic, Inc.
$17
Daiichi Sankyo Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
Dynavax Technologies Corporation
$16
Medtronic USA, Inc.
$13
GI Supply, Inc.
$12
Allergan Inc.
$11
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · Aemcolo · All Products · Axonics · BREZTRI · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · FARXIGA · FREESTYLE LIBRE 3 · GEMTESA · GI Genius · GIMOTI · GIVLAARI · HUMIRA · Heplisav-B · IBSRELA · INJECTAFER · INTERSTIM · IQIRVO · JARDIANCE · Kerendia · LINX Reflux Management System · LINZESS · MAVYRET · MOVIPREP · Mavyret · Movantik · OCALIVA · PillCam · Prolia · REBYOTA · RELISTOR · REMICADE · RESMETIROM · RINVOQ · Rybelsus · SKYRIZI · STELARA · SUTAB · TECENTRIQ · TRULANCE · Talicia · Tecentriq · Trulance · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,306 per 100 Medicare services performed
Looking for a gastroenterology specialist in Kissimmee?
Compare gastroenterologists in the Kissimmee area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
99
Per 100K population
24.3
County median income
$68,711
Nearest hospital
HCA FLORIDA OSCEOLA HOSPITAL
4.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Atiquzzaman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Atiquzzaman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Atiquzzaman performed 245 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atiquzzaman receive payments from pharmaceutical companies?
Yes. Dr. Atiquzzaman received a total of $9,754 from 51 companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atiquzzaman's costs compare to other gastroenterologists in Kissimmee?
Dr. Atiquzzaman's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atiquzzaman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →